EURACAN

EURACAN is part of the 24 European Reference Networks (ERNs) funded by the European Commission and dedicated to rare diseases. EURACAN is the ERN for Rare Adult Solid Tumours. The network comprises 102 highly specialised cancer centres across 25 European countries, 12 European Patient Advocacy Groups, international scientific societies and national rare cancer networks. The mission of EURACAN, based on its network of expert centres, is to share expertise and improve access to care for patients across the European Union. Further goals include increasing access for patients with rare adult solid cancers to expert centres, disease information, treatment options, and better healthcare, involving patient advocacy groups, developing Clinical Practice Guidelines, and training healthcare professionals. EURACAN aims to set up a clinical registry to help describe the natural history of rare adult solid cancers, evaluate factors that influence prognosis, assess treatment effectiveness, and measure indicators of quality of care. EURACAN focuses on cutting-edge brain tumor management, emphasizing diagnostic innovations, breakthrough therapies, and supportive care innovations to improve patient outcomes. Support for Rare Cancer Patients. Our members, healthcare providers with expertise in the management of rare cancers, particularly those located in the countries currently receiving large numbers of refugees (Czech Republic, Hungary, Poland and Romania) are ready to help Ukrainian patients with rare cancers.